RumbleOn, Inc. Announces Financial Results for the Third Quarter 2017
Nov 09, 2017 11:30 am UTC| Business
CHARLOTTE, N.C., Nov. 09, 2017 -- RumbleOn, Inc. (NASDAQ:RMBL), a disruptive e-commerce platform facilitating the ability of both consumers and dealers to buy, sell, trade, and finance pre-owned motorcycle and other...
Daseke, Inc. Announces Third Quarter 2017 Earnings
Nov 09, 2017 11:30 am UTC| Business
ADDISON, Texas, Nov. 09, 2017 -- Daseke, Inc. (NASDAQ:DSKE) (NASDAQ:DSKEW), the largest owner and a leading consolidator of flat bed and specialized transportation solutions in North America, today announced earnings...
WOWIO, INC. Acquires Land to be developed into low cost housing in Northern California
Nov 09, 2017 11:30 am UTC| Business
WOWIO Continues to Build its base of new Businesses Henderson, NV, Nov. 09, 2017 -- Wowio, Inc. (OTC Pink: WWIO) “WWIO or The Company” has entered into an agreement for its wholly owned subsidiary to purchase 100% of...
Arizona Mining Reports High Grade Infill and Step-Out Holes in Feasibility Drilling
Nov 09, 2017 11:30 am UTC| Business
VANCOUVER, B.C., Nov. 09, 2017 -- Arizona Mining Inc. (TSX:AZ) (“Arizona Mining” or the “Company”) announces strong results for seven exploration holes from the current drill program focused on expansion of the Taylor...
Epizyme to Present at the Jefferies 2017 London Healthcare Conference
Nov 09, 2017 11:30 am UTC| Business
CAMBRIDGE, Mass., Nov. 09, 2017 -- Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today announced that management will present a company overview at the...
Superconductor Technologies Reports 2017 Third Quarter Results
Nov 09, 2017 11:30 am UTC| Business
– Successfully completed third party validation test for target application –– Shipped Conductus wire to target customers –– Attained NEW record current carrying performance – AUSTIN, Texas, Nov. 09, 2017 --...
Histogenics Corporation Announces Third Quarter 2017 Financial and Operating Results
Nov 09, 2017 11:30 am UTC| Business
Top-line, 1-year Superiority Data for NeoCart® Phase 3 Clinical Trial and Potential Biologics License Application Filing Remain on Track for Third Quarter of 2018 Company to Host Conference Call and Webcast Thursday,...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update